North America Healthcare Disinfectant Wipes Market (2026 - 2033)

North America Healthcare Disinfectant Wipes Market Summary

The North America healthcare disinfectant wipes market size was valued at USD 667.3 million in 2025 and is projected to grow from USD 704.2 million in 2026 to USD 1,026.5 million by 2033, at a CAGR of 5.5% from 2026 to 2033. The market growth is driven by the increasing emphasis on healthcare-associated infection (HAI) prevention, stringent infection control regulations, growing adoption of ready-to-use disinfectants across healthcare facilities, rising demand for faster-acting, broad-spectrum disinfectant chemistries, and continuous innovation in sustainable, high-performance wipe technologies.

The North America healthcare disinfectant wipes industry is witnessing steady growth as healthcare providers intensify environmental cleaning protocols to reduce the transmission of healthcare-associated infections (HAIs) and multidrug-resistant organisms (MDROs). Hospitals, ambulatory surgery centers, long-term care facilities, and outpatient clinics are increasingly adopting pre-saturated disinfectant wipes because they offer standardized disinfectant dosing, shorter contact times, improved workflow efficiency, and reduced cross-contamination compared to reusable cloth-based cleaning systems. The growing prevalence of pathogens such as Candida auris, Clostridioides difficile (C. difficile), methicillin-resistant Staphylococcus aureus (MRSA), and vancomycin-resistant enterococci (VRE) has further accelerated the use of EPA-registered disinfectant wipes capable of meeting stringent infection prevention requirements. Additionally, increasing procedural volumes and higher patient throughput across healthcare settings continue to drive routine consumption of surface disinfectant wipes.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

The market is also benefiting from continuous innovation in disinfectant chemistries and wipe substrates. Manufacturers are increasingly introducing accelerated hydrogen peroxide, improved alcohol-based, and next-generation quaternary ammonium formulations that provide broader antimicrobial efficacy, shorter kill times, reduced residue, and enhanced compatibility with sensitive medical equipment. At the same time, healthcare systems are seeking products that combine infection prevention with sustainability goals, encouraging the commercialization of biodegradable, plastic-free, and refill-compatible disinfectant wipe solutions. Product development is increasingly focused on balancing clinical efficacy, user safety, equipment compatibility, and environmental performance, enabling suppliers to differentiate their offerings in a highly regulated market.

Another significant trend shaping the market is the expansion of outpatient healthcare services and the digitalization of infection prevention practices. The rapid growth of ambulatory surgery centers, urgent care clinics, dialysis centers, and physician offices has increased demand for convenient, ready-to-use disinfectant wipes that enable rapid room turnover between patients without disrupting clinical workflows. Simultaneously, healthcare organizations are strengthening compliance with standardized cleaning protocols through environmental monitoring programs, staff training, and infection prevention audits, resulting in more consistent use of disinfectant wipes across care settings. As healthcare providers continue to prioritize patient safety, regulatory compliance, and operational efficiency, disinfectant wipes are evolving from routine cleaning supplies into essential components of comprehensive infection prevention and environmental hygiene strategies.

Market Dynamics

Analyst Perspective

The North America healthcare disinfectant wipes market is being driven by the transition toward faster-contact-time, broad-spectrum disinfectant formulations that improve clinical workflow while meeting increasingly stringent infection prevention protocols. Hospitals are replacing legacy quat-based products with hydrogen peroxide, alcohol, and other advanced chemistries that demonstrate efficacy against emerging pathogens such as Candida auris and Clostridioides difficile. Sustainability is also influencing procurement decisions, with healthcare providers evaluating plastic-free and biodegradable wipe substrates that do not compromise disinfectant performance. In parallel, the expansion of outpatient care and stricter environmental hygiene standards are boosting wipe consumption beyond acute-care hospitals, while manufacturers are differentiating themselves through EPA registrations, material compatibility, and workflow-efficient packaging formats.

Product Insights

Quaternary Ammonium Compounds (Quats) healthcare disinfectant wipes dominated the North America healthcare disinfectant wipes market, accounting for the largest revenue share of 34.9% in 2025, driven by their broad-spectrum antimicrobial efficacy, material compatibility, and cost-effectiveness across routine healthcare disinfection applications. Quat-based wipes are widely used to clean high-touch environmental surfaces, patient rooms, nursing stations, outpatient clinics, and non-critical medical equipment, where frequent disinfection is required without causing corrosion or damage to sensitive materials. Their widespread EPA registrations, favorable contact times, and compatibility with plastics, stainless steel, and electronic equipment have made them the preferred choice for daily environmental cleaning in hospitals and long-term care facilities. In addition, their long-established inclusion in hospital infection prevention protocols and extensive product availability from leading manufacturers continue to support their dominant market position.

To learn more about this report, Download Free Sample Report

The hydrogen peroxide segment is expected to grow at the fastest CAGR of 8.9% from 2026 to 2033, driven by the increasing shift toward next-generation disinfectant chemistries with improved efficacy against emerging pathogens and better environmental profiles. Accelerated hydrogen peroxide (AHP)-based wipes offer rapid kill times against bacteria, viruses, fungi, and difficult pathogens such as Candida auris, while leaving minimal residue compared with conventional quat formulations. Growing concerns about disinfectant residue, occupational safety, and environmental sustainability are prompting healthcare facilities to transition to hydrogen peroxide-based wipes for routine environmental cleaning.

Pack Format Insights

Canister/tub (rigid dispenser) healthcare disinfectant wipes dominated the North America healthcare disinfectant wipes industry, accounting for the largest revenue share of 54.0% in 2025,primarily due to their convenience, contamination control, and suitability for high-frequency use in healthcare settings. These dispensers enable one-handed dispensing while minimizing wipe drying and cross-contamination, making them ideal for placement in patient rooms, nursing stations, operating rooms, and diagnostic laboratories. Their compatibility with infection prevention workflows, ease of storage, and availability in multiple wipe counts have made canister formats the standard packaging choice across hospitals and outpatient facilities.

To learn more about this report, Download Free Sample Report

The bucket/pail (bulk container) segment is projected to grow at the fastest CAGR of 6.8% from 2026 to 2033. The segment growth is driven by increasing demand from large healthcare facilities seeking operational efficiency and lower per-wipe costs. Bulk containers are widely adopted in hospitals, healthcare networks, and environmental services departments where high volumes of disinfectant wipes are consumed daily. Their larger capacities reduce replacement frequency, improve inventory management, and lower packaging waste relative to multiple smaller canisters.

Wipe Count per Pack Insights

The 101 to 150 wipes segment accounted for the largest revenue share of 32.7% in 2025, as this pack size provides the optimal balance between product longevity, ease of handling, and disinfectant stability in healthcare environments. Hospitals, outpatient clinics, and physician offices widely prefer this configuration because it supports frequent daily disinfection without requiring constant replacement, while minimizing the risk of wipes drying out after prolonged opening. The format is well-suited for patient rooms, nursing stations, and mobile cleaning carts where moderate-to-high consumption occurs throughout the day. Additionally, leading manufacturers have standardized many of their flagship disinfectant wipe products in the 100–150 wipe range, making it the most commonly procured pack size through healthcare distribution channels and group purchasing organizations (GPOs).

To learn more about this report, Download Free Sample Report

The 151 to 200 wipes segment is expected to grow at the fastest CAGR of 7.7% from 2026 to 2033. The segment growth is driven by healthcare providers' efforts to improve operational efficiency and reduce the total cost of consumables. Larger wipe-count packs reduce replacement frequency, lower packaging costs per wipe, and support uninterrupted cleaning workflows in high-traffic environments such as emergency departments, intensive care units, surgical suites, and environmental services departments. The growing emphasis on centralized procurement, bulk purchasing agreements, and inventory optimization across integrated healthcare systems is further accelerating demand for higher-capacity packs.

Facility Type Insights

The hospitals segment dominated the North America healthcare disinfectant wipes industry, accounting for the largest revenue share of 46.5% in 2025, owing to their high patient volumes, stringent infection prevention requirements, and continuous need for environmental and medical equipment disinfection. Acute care hospitals consume large quantities of disinfectant wipes across patient rooms, operating theatres, intensive care units, emergency departments, diagnostic imaging suites, and high-touch common areas to reduce the risk of healthcare-associated infections (HAIs). The growing prevalence of multidrug-resistant organisms (MDROs), Candida auris, and Clostridioides difficile has further increased the frequency of surface disinfection, reinforcing demand for EPA-registered healthcare disinfectant wipes with rapid contact times.

To learn more about this report, Download Free Sample Report

The ambulatory & outpatient care centers segment is expected to grow at the fastest CAGR of 10.7% from 2026 to 2033. The segment growth is driven by the rapid shift of healthcare services from inpatient hospitals to lower-cost outpatient settings. The expansion of ambulatory surgery centers (ASCs), urgent care clinics, dialysis centers, specialty clinics, and physician offices has significantly increased the need for fast, ready-to-use surface disinfection between patient visits. Unlike hospitals, these facilities require rapid room turnover and minimal workflow disruption, making pre-saturated disinfectant wipes the preferred solution over liquid disinfectants.

Country Insights

The North America healthcare disinfectant wipes market’s growth is driven by stringent infection prevention standards, high healthcare expenditure, and widespread adoption of ready-to-use surface disinfectants across hospitals, ambulatory care centers, long-term care facilities, and diagnostic laboratories. The region benefits from well-established regulatory frameworks led by the U.S. Environmental Protection Agency (EPA) and Health Canada, which promote the use of registered disinfectant products with proven efficacy against healthcare-associated pathogens. Growing concerns surrounding Candida auris, Clostridioides difficile (C. diff), and other multidrug-resistant organisms (MDROs), coupled with increasing demand for faster contact times, low-residue chemistries, and sustainable wipe substrates, continue to drive product innovation. The strong presence of major manufacturers such as PDI, Clorox Healthcare, Ecolab, STERIS, Kimberly-Clark Professional, and Diversey further reinforces North America's leadership in the market.

U.S. Healthcare Disinfectant Wipes Market Trends

The U.S. dominated the North America healthcare disinfectant wipes industry with an 88.2% revenue share in 2025, supported by its extensive healthcare infrastructure, high procedural volumes, and stringent infection control requirements across acute care hospitals and outpatient facilities. Increasing emphasis on preventing healthcare-associated infections (HAIs), coupled with CDC guidance for pathogens such as Candida auris and Clostridioides difficile, has accelerated the adoption of EPA-registered disinfectant wipes with broad-spectrum efficacy and shorter contact times. The market is further supported by strong purchasing activity through group purchasing organizations (GPOs), continuous product innovation in accelerated hydrogen peroxide and biodegradable wipe technologies, and the presence of leading domestic manufacturers.

Canada Healthcare Disinfectant Wipes Market Trends

The Canada healthcare disinfectant wipes market is projected to grow at a CAGR of 5.8% from 2026 to 2033, driven by increasing investments in infection prevention across hospitals, long-term care facilities, and community healthcare settings. Rising awareness of healthcare-associated infections, particularly following enhanced infection control practices adopted in recent years, is encouraging healthcare providers to transition toward high-performance disinfectant wipes with improved efficacy and environmental profiles. Health Canada's regulatory oversight, along with the growing procurement of environmentally preferable healthcare products, is accelerating the adoption of hydrogen peroxide-based, plastic-free disinfectant wipes.

Key North America Healthcare Disinfectant Wipes Company Insights

The North America healthcare disinfectant wipes market is characterized by a moderately consolidated competitive landscape, with leading multinational infection prevention companies competing alongside specialized healthcare disinfectant manufacturers. Competition is primarily centered on disinfectant efficacy, EPA and Health Canada regulatory approvals, contact time, compatibility with sensitive medical equipment, sustainability, product portfolio breadth, and healthcare distribution networks. Companies are increasingly investing in accelerated hydrogen peroxide formulations, biodegradable wipe substrates, refill systems, and pathogen-specific claims (including Candida auris and Clostridioides difficile) to strengthen their competitive position across hospitals, ambulatory care centers, and long-term care facilities.

• Hospital-Grade Surface Disinfection & Infection Prevention Specialists: Companies such as PDI, Inc. (Professional Disposables International), Metrex Research, Contec Incorporated, and Virox Technologies Inc. are recognized as leading specialists in healthcare surface disinfection. These companies compete through extensive portfolios of EPA-registered hospital disinfectant wipes designed for operating rooms, intensive care units, laboratories, cleanrooms, and patient care environments. Their competitive advantage is driven by broad-spectrum antimicrobial efficacy, rapid contact times, compatibility with medical devices, and continuous product innovation targeting emerging pathogens.

• Integrated Healthcare & Hygiene Solution Providers: Companies including Ecolab Inc., Diversey, GOJO Industries, Kimberly-Clark Corporation, and Medline leverage comprehensive infection prevention portfolios that combine disinfectant wipes with hand hygiene products, environmental cleaning solutions, medical consumables, and infection control services. These companies benefit from long-standing relationships with hospitals and integrated healthcare systems, extensive direct sales and distribution networks, and the ability to offer bundled infection prevention solutions. Increasing investments in environmentally sustainable formulations, refillable dispensing systems, and digital compliance solutions further strengthen their competitive positioning.

• Broad-Spectrum Cleaning & Consumer Healthcare Brands: The Clorox Company maintains a strong presence in the healthcare disinfectant wipes market through its Clorox Healthcare product portfolio, offering EPA-registered disinfectant wipes specifically developed for healthcare environments. The company differentiates itself through broad pathogen efficacy claims, including sporicidal and hydrogen peroxide-based technologies, extensive healthcare distribution, and continuous innovation focused on faster contact times, improved material compatibility, and reduced environmental impact. Alongside specialized healthcare manufacturers, Clorox continues to expand its portfolio to meet evolving infection prevention standards and sustainability requirements across North American healthcare facilities.

  

  To learn more about this report, Download Free Sample Report

Key North America Healthcare Disinfectant Wipes Companies

• Metrex Research

• Virox Technologies Inc.

• Ecolab Inc.

• The Clorox Company

• Medline

• Kimberly-Clark Corporation

• PDI, Inc. (Professional Disposables International)

• Diversey

• GOJO Industries

• Contec Incorporated

Recent Developments

• In June 2026, Clorox Healthcare launched two new disinfecting solutions to strengthen infection prevention in healthcare facilities: Quat Alcohol Disinfecting Wipes with a 1-minute contact time and 40% less alcohol, and HyperOxi Disinfecting Wipes, its first bleach-free sporicidal wipes. The innovations are designed to improve compliance, streamline cleaning workflows, and enhance protection against emerging pathogens.

• In October 2025, Metrex launched CaviCide™ HP, a ready-to-use hydrogen peroxide-based liquid surface disinfectant for healthcare environments. The product provides broad-spectrum disinfection against 70 labeled pathogens with a one-minute contact time. Free of bleach and alcohol, it requires no dilution and features a low-toxicity formulation, strengthening Metrex's environmentally conscious infection prevention portfolio.

• In August 2025, Metrex entered a strategic partnership with the Association for Professionals in Infection Control and Epidemiology (APIC) as a Visionary Strategic Partner. The collaboration strengthens engagement with APIC's network of more than 15,000 infection prevention professionals, supporting education, research, innovation, and advocacy while advancing infection prevention practices and improving healthcare safety worldwide.

• In May 2025, CloroxPro entered a partnership with Vizient to supply a broad portfolio of cleaning and disinfection solutions, including Clorox Healthcare disinfectant wipes, to healthcare providers across the U.S. The agreement expands access to infection prevention products, helping hospitals strengthen environmental hygiene and reduce the risk of healthcare-associated infections.

• In July, 2024, Ecolab launched Disinfectant 1 Wipe, the first EPA-registered 100% plastic-free, wood pulp-based hospital disinfectant wipe. Designed for healthcare facilities, the readily degradable wipe provides one-minute disinfection against over 40 pathogens, kills SARS-CoV-2 in 30 seconds, and supports sustainability by reducing plastic waste and lowering overall wipe usage compared with conventional alcohol-based disinfectant wipes.

North America Healthcare Disinfectant Wipes Market Report Segmentation

This report forecasts revenue growth at the regional & country levels and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2026 to 2033. For this study, Grand View Research has segmented the North America healthcare disinfectant wipes market report based on product, pack format, wipe count per pack, facility type, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Alcohol-Based Disinfection Wipes

  • Quaternary Ammonium Compounds (Quats)

  • Hydrogen Peroxide

  • Chlorine Compounds

  • Citric Acid

  • Phenolic Compounds

  • Lactic Acid

  • Biguanides

  • Peracetic Acid

  • Others

• Pack Format Outlook (Revenue, USD Million, 2021 - 2033)

  • Soft Pack (Flexible Pouch)

  • Canister/Tub (Rigid Dispenser)

  • Bucket/Pail (Bulk Container)

  • Individual Sachet (Unit-Dose)

• Wipe Count per Pack Outlook (Revenue, USD Million, 2021 - 2033)

  • Up to 50 Wipes

  • 51 to 100 Wipes

  • 101 to 150 Wipes

  • 151 to 200 Wipes

  • Above 200 Wipes

• Facility Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals

  • Ambulatory & Outpatient Care Centers

  • Long-Term & Post-Acute Care Facilities

  • Diagnostic & Laboratory Facilities

  • Dental Care Facilities

  • Emergency & Pre-Hospital Care

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

Research Methodology

The North America healthcare disinfectant wipes market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing-reconciling supply-side and demand-side estimates-and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each North America healthcare disinfectant wipes segment quantified using the revenue-capture definitions in the table below.

Estimation Model

Each layer progressively narrows the population pool and applies a conversion rate to arrive at addressable revenue.

Delivered Customizations

This report has been delivered with the following In-depth customizations